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Abstract: The Swiss Society for Microbiology (SSM) represents around 700 scientists working in the fields of
medical (human and veterinary), microbial biotechnology as well as fundamental, environmental, and food
microbiology. Five sections: Clinical Microbiology, Environmental Microbiology, Mycology, Prokaryotic Biology,
and Virology reflects the main interests of the membership.
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Introduction
The Swiss Society for Microbiology
(SSM) is an association gathering Swiss
microbiologists, i.e. more than 700 per-
sons, working with microbes. The SSM is
active in the fields of medical (human and
veterinary), microbial biotechnology as
well as fundamental, environmental, and
food microbiology. It includes the study of
all microbes, including bacteria, viruses,
parasites and fungi, whatever their patho-
genic role or their symbiotic nature. Also
broad in scope and open to all scientists
studying microbes, the current member
composition, biased towards bacteriolo-
gists, virologists and mycologists, led to
the constitution of five sections:
· Clinical Microbiology
· Environmental Microbiology
· Mycology
· Prokaryotic Biology
· Virology
The SSM promotes the advancement
of all these disciplines by organizing an-
nual meetings and workshops, and by
participating in current political and pub-
lic microbiology-related debates for the
benefit of our society. Thus, the SSM also
aims at being active in lay communication,
which is of prime importance to promote
future careers in microbiology among the
youngest, but also to advance communica-
tion at the political & societal level, since
microbes are so important in many of our
everyday activities, such as food (just think
of lactobacilli and yoghurt for example).
The importance of microbes as human
pathogens extends far beyond their role in
the pathogenesis of infectious diseases as
demonstrated by their role in non-infec-
tious human disease such as obesity and
asthma. Moreover, the role of pathogenic
microbes extends to pathogens of animals
(including domestic animals, cattle, wild-
life mammals, and fish), arthropods, plants
and algae.
Bacteria and viruses being on earth
for about 2 billion years earlier than eu-
karyotes, our society also includes several
scientists fascinated by evolution and ex-
ploring the origin of life. Thus, the SSM
bridges several specialities and partially
overlaps with ecology, entomology, vet-
erinary science, medicine, and biotech-
nology. Consequently, another task of the
SSM is to advance the communication and
exchange of scientific information among
its members and other Swiss scientists.
Special attention is given to the encour-
agement and career development of young
and promising members by granting an an-
nual SSM promotion award as well as by
supporting PhD students and young post-
docs with travel fellowships. This year,
M. Stragiotti, F. Oechslin and P. V'kovski
received the SSM poster award whereas G.
Panis, received the SSM Encouragement
award (Fig. 1).
Clinical Microbiology
Clinical bacteriology has benefit-
ted from major improvements in the last
decade, and is about to be substantially
transformed in the years to come. While
the concept of culturing that is at the
root of conventional bacteriology has not
changed much since the Pasteurian times,
the identification of bacteria and fungi has
considerably been improved and acceler-
ated (it requires 24 h now vs. 48 h before,
i.e. through the use of MALDI-TOF
[1]
mass spectrometry). The automation of
laboratories that is currently being imple-
mented should bring more standardization
in the diagnostic process and improve the
overall quality of results.
[2]
Still, the big-
gest clinical issue in infections is resis-
tance to antibiotics.
[3,4]
In this field, very
few improvements have been achieved
and it currently takes at least 48 h to test
the antibiotic susceptibility of the patho-
gens. During this time window, the patient
is given a probabilistic antibiotic regimen
that has to be active should the pathogen
be antibiotic-resistant, but also not too
broad to avoid the selection of resistant
bacteria. So far, this Janus dilemma is not
addressed by the latest techniques avail-
able in our laboratories. Nonetheless, the
situation could change with the application
of next-generation sequencing (NGS) tools
directly on clinical samples, which can be
referred to as clinical metagenomics.
[5]
Indeed, the depth of sequencing should al-
low the recovery of the genetic information
related to the pathogens putatively present
in sample such as their identification, their
antibiotic resistance genes (ARGs) and
mutations leading to resistance. Still, sev-
eral issues need to be tackled before clini-
cal metagenomics can be applied in routine
laboratories, namely the cost, turn-around
time, human DNA removal, inference of
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many research questions of environmental
microbiology to be answered. Such an ap-
proach has shown that there was not only
an extensive taxonomic overlap between
the Arabidopsis leaf and root microbiota
but also a large overlap of genome-en-
coded functional capabilities.
[13]
Finally,
nucleic acid-based techniques also enable
the investigation of bacterial pure cultures
introduced into an environmental compart-
ment. Sphingomonas wittichii strain RW1
for example was inoculated into soil to
achieve increased pollutant degradation.
It displayed a very different transcrip-
tome signature than in liquid culture and
evidence for numerous ‘soil-specific’ ex-
pressed genes was obtained.
[14]
Mycology
Activities in the section of Mycology,
that are carried out under the flagship of the
Swiss Society of Microbiology, are very
diverse. The activities can be divided into
different subcategories that reflect current
research interests in the fungal community
in Switzerland. The major fields of inter-
est include Medical Mycology, Molecular
and Cellular Biology of Yeast, Molecular
Biology of Filamentous Fungi and Fungal
Plant Pathogens. ‘Omics’-technologies
have changed the way that research is car-
ried out in microbiology across all types of
microbial agents. In the field of Mycology,
the progresses made during the past years
in the area of genomics, including high-
throughput deep-sequencing and tran-
scriptomics, permit nowadays to undertake
metagenomics approaches where all is se-
quenced or with more targeted approaches
where specific genes are investigated. In
a study investigating the effect of long-
term organic and conventional farming
on soil microbial diversity using a high-
throughput pyrosequencing approach of
bacterial and fungal ribosomal markers it
was shown that organic farming increased
richness, decreased evenness, reduced
dispersion and shifted the structure of the
soil microbiota compared to conventional
managed soils.
[10]
An investigation of the
abundance of antibiotic resistance genes in
21 Swiss lakes using quantitative real-time
PCR indicated higher abundance of certain
of these genes with increasing number and
capacity of wastewater treatment plants
in the catchment.
[11]
Another approach to
analyze microbial communities are the in
situ analyses where the cells are kept in-
tact by fixation techniques and the nucleic
acids inside the cells are used for analy-
sis. A combination of fluorescence in situ
hybridization and flow cytometry made it
possible, after multiple efforts of technique
optimization, to extract ultramicrobacteria
affiliated with LD12 Alphaproteobacteria
from the rest of the microbial communi-
ty in the water of the lake – an achieve-
ment that had not been possible until now
with traditional techniques.
[12]
Despite the
huge increase in understanding microbial
community composition and functioning
in numerous environmental systems, it
became evident in recent years that only
the combination of these novel nucleic
acid-based techniques with traditional
and novel culturing approaches will allow
the antibiotic susceptibility profile from
metagenomic data and linkage between
ARGs and their host. Then, NGS could en-
ter the routine laboratories through whole
genome sequencing (WGS). Indeed, WGS
has been shown to be a promising tool
for assessing the relationships between
strains,
[6,7]
the detection of ARGs (in case
of suspicion ofmultidrug-resistant bacteria
such as those producing carbapenemase)
[8]
or even the antibiotic susceptibility infer-
ence for fastidious-growing bacteria such
as Mycobacterium tuberculosis.
[9]
The use
of NGS in clinical practice was extensively
addressed during the Swiss MedLab 2016
in Bern (organized by the Swiss Union
of Laboratory Medicine) and will be fur-
ther discussed in the first International
Conference on Clinical Metagenomics
(October 13–14, 2016 in Geneva). In all,
we believe that the next decades for clini-
cal bacteriology are expected to include
more automation, more bio-informatics,
and fewer cultures.
Environmental Microbiology
Similar to clinical bacteriology, envi-
ronmental microbiology has made major
progress in the last decade due to tech-
niques that do not require cultivation of mi-
croorganisms. For so-called ex situ analy-
ses, DNA and RNA are extracted from
samples originating from such complex
environments as soils, aquifers, lake water
and sediments, and biological treatment
systems purifying wastewater. The nucle-
ic acids are subsequently analyzed with
Fig. 1. The SSM is encouraging PhD students and postdocs by giving three poster prizes (left) and one career encouragement award (right) each
year. The poster prizes are sponsored by BioMérieux.
876 CHIMIA 2016, 70, No. 12 Life ScienceS in SwitzerLand
enzymes are inactivated by the toxins by
a modification known as adenylation.
[21]
TheViollier lab studied a different class of
toxins that degrades mRNA and showed
that stress cause by DNA damage acti-
vates this toxin system to inhibit growth of
Caulobacter.
[22]
A recent benchmark paper
from the Jenal team published in Nature
[23]
showed that the ubiquitous second (di-
nucleotide) messenger cyclic diguanylate
acts as tuner of cell cycle progression, li-
censing the onset of DNA replication by
reversing the phosphate flow through an
essential cell cycle kinase in the model
system Caulobacter. A burst of cyclic
diguanylate precedes the onset of DNA
replication, explaining how the reversal in
phosphosignaling is regulated in time.
Virology
Emerging and zoonotic viruses have
received increased public attention during
the past years.TheMiddleEastRespiratory
Syndrome (MERS) Coronavirus outbreak
in 2012, the crisis in Africa with the out-
break of Ebola Virus, and the recent ap-
pearance of ZikaVirus, has keptmany virus
laboratories busy world-wide, including
Switzerland. Particularly the Ebola Virus
outbreak exemplified that such events not
only impact the countries that are directly
affected. ‘Raising Preparedness’ appeared
to be important in manyways. For example
diagnostic tests have to be established and
implemented
[24]
for the case that travellers
bring the Ebola Virus home from other
countries. In addition, patient treatment
under conditions of highest containment is
needed to provide medical care of highest
standard and at the same time to guaran-
tee that the virus will not spread further
inside or outside hospitals. The Geneva
University Hospitals had been challenged
with a case of a 43-year-old medical doctor
who contracted an Ebola virus infection in
Sierra Leone in November 2014 and was
airlifted to Geneva University Hospitals
on day 5 after disease onset.
[25]
Due to the
high standard of medical care and immedi-
ate treatment the patient recovered rapidly,
despite an initial high viral load. The ex-
perience gained in such emergency units
is invaluable and provides an impetus for
further improved diagnostic methods and
for a better understanding of Ebola Virus
pathogenesis and evolution.
[25]
This ex-
perience is currently needed as more and
more cases of ZikaVirus infections appear.
Differential diagnosis is often needed due
to simultaneous outbreaks of viruses, such
as Dengue Virus and Chikungunya Virus,
that show similar disease symptoms.
[26]
Emerging and zoonotic viruses will cer-
tainly continue to keep virologists busy.
The more we learn, and the more we know
it also provides insight into the principal
mechanisms that most primordial cells use
to control growth.
Bacteria can regulate their growth from
within using venoms that are activated at
times of stress, but also from outside us-
ing venomous harpoons that are deployed
from competing bacteria. These venoms
intoxicate their prey, arresting their growth
and ultimately causing their lysis. The
structure of the harpoon gun (also known
as the type six secretion system, T6SS) re-
sembles the puncturing device that bacte-
riophages usewhen infecting prey. In a tour
de force of structural biology, Petr Leiman
at EPF Lausanne and colleagues from the
Biozentrum Basel recently illuminated
the structure of the T6SS and phage har-
poon guns and described in Nature
[17]
how
matching structural transitions in the con-
stituents of T6SS and phage device occur
at the atomic level. The team of Melanie
Blokesch at the Global Health Institute
of EPFL recently unveiled a new master
transcriptional regulator of the T6SS in the
cholera pathogen Vibrio cholerae.
[18]
They
showed that the TfoY integrates nutritional
(environmental) and cell density signals to
active expression of the T6SS and that the
TfoY regulon only partially overlaps with
that of the related protein TfoX. Might
these proteins implement different fates in
different Vibrio cholerae cells?
A distinctive fate of Pseudomonas cells
has also been observed by Jan van der
Meer and colleagues at the University of
Lausanne.
[19]
In this case they used clever
tricks to indirectly visualize the excision,
transfer and re-integration of a mobile
genetic element from the chromosome
of a donor cell into the chromosome of a
recipient cell. By tracing each cell’s his-
tory by imaging the transfer of the genetic
element, they define the donor cell by re-
duced cell division rates or growth arrest,
persistence, or lysis after the transfer has
started. In a similar approach Mathis et al.
also traced the Caulobacter cell history by
live cell imaging in microfluidic devices
after salt stress to monitor the history-de-
pendence of bacterial stress responses.
[20]
They observed the emergence of memory-
like behaviour at the level of the popula-
tion, indicating that past events can indeed
modulate the behavioural traits of individ-
uals and groups of bacteria.
Two different bacterial growth con-
trol mechanisms operating from within
are reported by the groups of Christoph
Dehio and Urs Jenal at the Biozentrum
Basel and the group of Patrick Viollier at
the University of Geneva. The Dehio lab
described the mechanism of action of a
new class of toxins that is activated inside
the bacterium to inhibit DNA replication
by modifying a special class of replication
enzymes known as topoisomerases. These
studies that were not possible or just cost-
prohibitive in the past.
For example, one of the challenges
is, when following microbes such as fun-
gal pathogens during a host infection,
that it is difficult to investigate or isolate
cells for further genome-wide transcrip-
tional analysis. When total RNA is ex-
tracted from infected tissues, the propor-
tion of fungal RNA is usually less than
1%, which makes it quite challenging to
undertake fungal transcriptomics in such
conditions. Recently, Amorim-Vaz et al.
from the CHUV in Lausanne addressed
this problem and applied a RNA enrich-
ment procedure for extracting Candida
albicans RNA from infected mice tissues.
[15]
This procedure is based on exome se-
quencing in mammals. The approach uses
120-mer oligonucleotide baits correspond-
ing to the ORFome of C. albicans (ap-
proximatively 6300 genes) and which are
able to capture C. albicans RNA. When
successful, the RNA capture is devoid of
most host RNA. From infected tissues,
Amorim-Vaz et al. were able to enrich up
to 1,600-fold the C. albicans RNA. This
allowed an unprecedented resolution of the
C. albicans transcriptome in vivo over the
time course of an infection in an animal
model and identified genes important for
C. albicans pathogenesis. Interestingly, the
fungal RNA enrichment procedure may be
applied to other microbial pathogens, as far
as their genomes are available.
The impact of genomics in fungal-ori-
ented research can be also observed in plant
pathology. Using genome wide association
studies (GWAS), a recent study performed
at the ETH Zurich identified in the plant
pathogen Fusarium graminearum candi-
date genes that affect specific quantitative
traits important fordiseasedevelopment.
[16]
Out of 220 investigated fungal strains, 74
quantitative trait nucleotides (QTNs) were
significantly associated to sensitivity of
azoles, which are widely used fungicides
for crop protection. Three QTNs associ-
ated with azole sensitivity were located in
genes not previously associated with this
phenotype. Such analyses may reveal criti-
cal genes that the fungus uses to develop
antifungal resistance, which could lead to
novel crop protection strategies. In con-
clusion, the development of efficient and
high-resolution genomic technologies has
profoundly changed the way fungal biol-
ogy can now be approached and will con-
tinue to do so.
Prokaryotic Biology
Understanding how prokaryote cells
grow and die not only dictates how we
can best intervene with them or reprogram
them to combat bacterial pathogens, but
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about these viruses, the better will be our
preparedness to future outbreaks.
Conclusion
The SSM is a very large and active so-
ciety, which tackles a variety of themes and
has members highly active in research, as
well as in R&D activities, as demonstrated
by the examples reported above. However,
to be really inserted in the real life, it is
essential for the SSM to also improve
further its communication to the general
population, by modifying the general
perception of microbes, from beneficial
servants, to accidental pathogens or even
malicious agents of bioterrorism. Indeed,
life has more evolved by cooperation than
by competition and most microbes are just
beneficial to life, with a major role in its
evolution.
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